Bold perspectives
“Much of the data that fuels modern medicine originates from clinical diagnostic tests, making laboratories essential to developing and implementing the personalized care solutions of the future.”
William Morice II, M.D., Ph.D., president and CEO, Mayo Clinic Laboratories
The latest
From personalized medicine to AI, discover how current trends are shaping the future of diagnostics and patient care.
Leveraging the Laboratory 2026 highlighted how labs can drive growth by embracing innovation, investing in people, and advocating for their value.
In a Becker’s Healthcare podcast, Dr. Bill Morice discusses precision medicine, AI, patient expectations, and challenges facing laboratories.
Christopher Garcia, M.D., on why a new generation of therapies puts laboratory medicine at the center of care, and how data and AI can help make sure patients never wait on the diagnostic.
Discover in a Becker’s Healthcare podcast how leaders can help teams navigate rapid change while staying grounded in mission, strategy, and values.
New wtRNA-seq test detects fusions in 1,445 genes with high accuracy, improving cancer diagnosis, treatment decisions, and clinical trial eligibility.
Discover how to create an approach to innovation that drive innovation with meaningful healthcare advancements.
As 2026 begins, Dr. Bill Morice shares his thoughts on the forces that will shape opportunities and challenges for the diagnostics industry this year.
Viral and pharmacogenomic testing help clinicians detect infection early, tailor immunosuppression, and improve long-term outcomes for organ transplant recipients.
Matthew Binnicker, Ph.D., shares strategies to speed diagnostic innovation while safeguarding quality and patient trust.
Dr. Morice highlights the role laboratorians play in ensuring new solutions support safe, effective patient care as platforms reshape healthcare.
Mayo Clinic Laboratories is transforming diagnostics with innovations in 2025 that turned research into real-world solutions for better patient care.
SAAmplify™-αSYN testing offers unprecedented accuracy in diagnosing Parkinson’s and Lewy body dementia.

Bold ideas drive discovery